Jean-Patrick Demonsang
Presidente presso Demonsang Consulting SAS
Posizioni attive di Jean-Patrick Demonsang
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| Demonsang Consulting SAS | Presidente | - | - |
Storia della carriera di Jean-Patrick Demonsang
Precedenti posizioni note di Jean-Patrick Demonsang
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| OSE IMMUNOTHERAPEUTICS | Direttore/Membro del Consiglio | 10/04/2014 | 22/06/2023 |
| Independent Dir/Board Member | 10/04/2014 | 22/06/2023 | |
Seventure Partners SA
 Seventure Partners SA Investment ManagersFinance Seventure Partners SA (Seventure) is a Venture Capital firm, a subsidiary of Natixis SA founded in 1997. Seventure Partners SA is headquartered in Paris. | Amministratore Delegato | 21/06/2010 | 01/01/2013 |
| Presidente | 01/09/1999 | 01/01/2013 | |
| Presidente | 01/09/1999 | 01/01/2013 | |
Natixis Venture Sélection SA
 Natixis Venture Sélection SA Investment ManagersFinance Natixis Venture Selection SA seeks to invest in French companies operating in a wide range of sectors, it focuses on early and later venture capital stages. | Direttore/Membro del Consiglio | - | - |
| Genode Partners SAS | Amministratore Delegato | - | - |
| Parexi SAS | Presidente | - | - |
| G1j Ile De France | Presidente | - | - |
Orphan Synergy Europe-Pharma SA
 Orphan Synergy Europe-Pharma SA Pharmaceuticals: MajorHealth Technology Orphan Synergy Europe-Pharma SA engages in the development of immunotherapy products against late stage cancer. Its products include Tedopi as treatment for lung cancer and Memopi technology which helps the immune system to eliminate malignant cells. The company was founded by Dominique Costantini and Emile Loria on November 17, 2004 and is headquartered in Paris, France. | Direttore/Membro del Consiglio | 10/04/2014 | - |
| Independent Dir/Board Member | 10/04/2014 | - |
Formazione di Jean-Patrick Demonsang
| École des Hautes Études Commerciales de Paris | Masters Business Admin |
Statistiche
Distribuzione geografica
| Francia | 10 |
Posizioni
| Chairman | 4 |
| Director/Board Member | 3 |
| Chief Executive Officer | 2 |
Settori
| Finance | 3 |
| Health Technology | 3 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| OSE IMMUNOTHERAPEUTICS | Health Technology |
| Aziende private | 7 |
|---|---|
Seventure Partners SA
Seventure Partners SA Investment ManagersFinance Seventure Partners SA (Seventure) is a Venture Capital firm, a subsidiary of Natixis SA founded in 1997. Seventure Partners SA is headquartered in Paris. | Finance |
Natixis Venture Sélection SA
Natixis Venture Sélection SA Investment ManagersFinance Natixis Venture Selection SA seeks to invest in French companies operating in a wide range of sectors, it focuses on early and later venture capital stages. | Finance |
Orphan Synergy Europe-Pharma SA
Orphan Synergy Europe-Pharma SA Pharmaceuticals: MajorHealth Technology Orphan Synergy Europe-Pharma SA engages in the development of immunotherapy products against late stage cancer. Its products include Tedopi as treatment for lung cancer and Memopi technology which helps the immune system to eliminate malignant cells. The company was founded by Dominique Costantini and Emile Loria on November 17, 2004 and is headquartered in Paris, France. | Health Technology |
| Demonsang Consulting SAS | |
| G1j Ile De France | |
| Parexi SAS | |
| Genode Partners SAS |
